Clinical Trials in Miami

Showing 6201-6220 of 11,431 trials

Study of Danicopan in Participants With Hepatic Impairment

NCT03555539

The purpose of this study was to evaluate the safety, tolerability, and pharmacokinetics (PK) of ACH-0144471 (danicopan) in participants with hepatic impairment (HI) as compared to healthy matched participants.

Hepatic Impairment

Alexion Pharmaceuticals, Inc.16 participantsStarted May 2018

Miami, Florida, United States • Orlando, Florida, United States

WITHDRAWNPhase 1< 1 mile

A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

NCT01510561

90Y-hPAM4 is administered weekly for 3 weeks combined with 4 weekly doses of gemcitabine to assess. This is a dose escalation study of 90Y-hPAM4 to assess which dose is safe and effective as 3rd line treatment for patients with metastatic pancreatic cancer. Patients are then followed weekly for 12 weeks and afterwards for up to 1 year.

Metastatic Pancreatic AdenocarcinomaPancreatic CancerMetastatic Pancreatic Cancer

Gilead SciencesStarted Mar 2012

Gilbert, Arizona, United States • Scottsdale, Arizona, United States • Newark, Delaware, United States +21 more locations

Study of Danicopan in Participants With Hepatic Impairment

A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

Find Trials by Condition in Miami

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

A Study of INCB050465 in Primary Sjögren's Syndrome

Investigation of Neural Stem Cells in Ischemic Stroke

A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

A Prospective Longitudinal Breast Cancer Study

A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

St.Jude Medical Cardiac Lead Assessment Study

Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS

Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial